Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. - Wikidata - wikimedia - TriplyDB

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

http://www.wikidata.org/entity/Q35854966

about

Immunomodulation on the ocular surface: a review Novel formulations for antimicrobial peptides Emerging treatment options for meibomian gland dysfunction.Recent patents on ophthalmic nanoformulations and therapeutic implications An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye A pilot study: the efficacy of virgin coconut oil as ocular rewetting agent on rabbit eyes.Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping.Preparation, characterization, and evaluation of antitumor effect of Brucea javanica oil cationic nanoemulsions.Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine Release.Emerging drugs for the treatment of dry eye disease.Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery.Topical delivery of ocular therapeutics: carrier systems and physical methods.An update on dry eye disease molecular treatment: advances in drug pipelines.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Surface Chemistry Interactions of Cationorm with Films by Human Meibum and Tear Film Compounds.Nanoemulsions: formation, properties and applications.Safety and toxicity of nanomaterials for ocular drug delivery applications.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Therapeutic approaches for the delivery of TNF-α siRNA.Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy.Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl.Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells.A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment Relevance of Lipid-Based Products in the Management of Dry Eye Disease.Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review.Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review.Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program.Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.Design, Synthesis, and Antibacterial Activity of a Multivalent Polycationic Calix[4]arene-NO Photodonor Conjugate.Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide.Keratitis in Dry Eye Disease and Topical Ciclosporin A.Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation.

P2860

Q26740643-2D0E0C18-03DF-4C4A-8976-F5F606511907 Q26991771-49D29316-11F6-4908-91A1-6ADFB4196521 Q34371781-8FF7E7F8-8E18-4107-8687-54B7247832A9 Q35043004-722693E9-E6C5-4B47-AD25-E73B453F9F74 Q35094304-FDD5ED17-1428-4ABB-8CCE-98616724EFBE Q35157303-0DC7CDAE-E2F7-4DE4-A599-0FEB18F0EDEF Q36182937-08F0EC00-3428-4368-8EB6-1C415EB7B3E6 Q36656777-EF221FB3-35B1-401D-A5D9-69C82418074A Q36981187-F2FECD04-4C0C-436C-945E-740349A154CE Q37602017-3671C9D6-9552-4D33-BD5F-BED886AA27A7 Q37627442-CD6297A5-8DEA-4CE8-9D3C-F7EA409C458A Q37638619-00840D25-CD65-40E0-A7F4-5B8FB52C3536 Q38102006-8A11BD99-106D-4880-AA32-3AC960C01D4B Q38133883-B9842C37-C6C3-4CE7-B037-00AB1F5F266B Q38196446-2C83435B-78EB-422E-8836-4701A7F5366E Q38207723-648D636D-657C-40F9-8745-831D9113B094 Q38648168-04518037-7846-4E59-BDC2-C8FACC8E2FEC Q38674125-2966A937-6679-4B92-864F-0232D763AA37 Q38754120-0463BB3B-C583-47EC-9257-04BC0D71380B Q38793489-6E6DCB69-54FF-4228-9660-8C0AE3B5136D Q39103248-00C5A69B-4C03-42A6-B26A-2E6E1335EDEE Q39210558-DE57F349-8963-446B-B43E-D989985ECADC Q39386513-73ACB175-8DAB-439C-BAF0-9E4410C9A81F Q40573088-48066374-0744-43E2-A184-6B8C0E1AE1BF Q40713954-CD400D20-1449-4A66-878A-A7002D9D51D9 Q41154638-53EC1993-2612-40A6-89AB-006C458795DE Q41442733-0EC77F7F-3F41-41C4-B5AB-A11D12029E7B Q43119649-0AA44702-93DB-41EB-93E2-E9AB4E969DDB Q47100458-B78FA7BB-E246-4607-B84A-6434862EAA39 Q49996892-0E71B289-3322-473E-8990-092BCA4A9E6A Q50025206-EF0D6DFD-1308-4735-9FD2-A4D89DE51CBA Q51787921-81E42428-9D8C-4341-9FA7-B849779D6354 Q51823285-CCE1CCE5-80F0-449B-87B2-7B97CA33893E Q53174701-D2CBED61-704C-41A1-B3C5-AE49308E358C Q53534950-97B8DE35-7810-4E20-898F-5A714306B566 Q54839313-CA3F899C-1D6E-4095-B69E-B16E97BB078A

P2860

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

http://www.wikidata.org/entity/Q35854966

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

@ast

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

@en

type

label

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

@ast

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

@en

prefLabel

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

@ast

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

@en

P1433

Q35854966-6440F1FB-66CD-47D9-9B1E-F3244231EC57

P1476

Q35854966-FD472F03-B23C-49C6-86B9-04E2CE43EC8D

P2093

Q35854966-2E67FF5E-95CE-4E8C-B831-4827EA182E6E

Q35854966-2ECFC7C6-DFE8-4517-BBDD-E8F77357FF26

Q35854966-47C6AD65-3A61-453E-9C84-7710CEDFDB52

Q35854966-AD17577E-B7FF-450B-86AB-EB85362F03B1

Q35854966-D00031E5-AF48-4975-B563-F78BDD6BB20E

P2860

Q35854966-059428CC-93C4-480A-BA95-40B451898BEA

Q35854966-07B0F60C-ABB2-4477-AC8B-4B4D8C232193

Q35854966-12AE67B9-7855-4D3C-89C6-1D008C41E112

Q35854966-18467736-5665-4533-80F9-919AD5EA2629

Q35854966-2065D179-394E-48EA-B6EA-D9EB7BF4D5B7

Q35854966-29AFFD84-6FD9-4C4E-B977-AF37034E33AB

Q35854966-2A0430DB-A762-43B8-AC74-6AE1B8BEC9D5

Q35854966-314920C1-76C2-449B-8BEB-7C011215587D

Q35854966-3272CA29-99C4-4CCE-B34A-F7C0A6107F92

Q35854966-3D4A7B08-69E5-4A9F-85F1-579A95BA9789

P304

Q35854966-E74BBC76-CFD4-482D-8999-F704A885C4AF

P31

Q35854966-D4DEBB10-A1D2-445C-8682-FB377CE6AA81

P356

Q35854966-9E139CEC-E797-4BD7-A358-51A945BE0D28

P478

Q35854966-1FB790FA-F3B3-4954-9C5A-3060E23C7138

P577

Q35854966-7C9209B0-0F2F-4C4B-926D-0420EE6B310D

P5875

Q35854966-2662A753-DB9A-4339-8982-C3A52024A950

P698

Q35854966-DEB3B427-D020-460F-8F00-40F051A90E1D

P921

Q35854966-38570866-CC2E-4767-A129-2484E0E065D5

P932

Q35854966-3EA184ED-0E1E-491A-8AE1-154EA52E3418

P356

P1433

Journal of Drug Delivery

P1476

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

@en

P2093

Frederic Lallemand

http://www.w3.org/2001/XMLSchema#string

Jean-Sebastien Garrigue

http://www.w3.org/2001/XMLSchema#string

Philippe Daull

http://www.w3.org/2001/XMLSchema#string

Ronald Buggage

http://www.w3.org/2001/XMLSchema#string

Simon Benita

http://www.w3.org/2001/XMLSchema#string

P2860

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.

A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes.

Extensive surface studies help to analyse zeta potential data: the case of cationic emulsions.

Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.

Prevention of topical and ocular oxidative stress by positively charged submicron emulsion.

Polymeric micelles comprising stearic acid-grafted polyethyleneimine as nonviral gene carriers.

Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution.

Physicochemical screening of antimicrobial agents as potential preservatives for submicron emulsions.

Ocular preparations: the formulation approach.

P304

604204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/604204

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224050323

http://www.w3.org/2001/XMLSchema#string

P698

22506123

http://www.w3.org/2001/XMLSchema#string

P921

P932

3313063

http://www.w3.org/2001/XMLSchema#string